David M. Goldenberg
2014
In 2014, David M. Goldenberg earned a total compensation of $2.6M as Chairman, Chief Scientific Officer and Chief Patent Officer at Immunomedics, a 62% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $286,403 |
|---|---|
| Option Awards | $350,035 |
| Salary | $584,495 |
| Stock Awards | $1,249,026 |
| Other | $153,187 |
| Total | $2,623,146 |
Goldenberg received $1.2M in stock awards, accounting for 48% of the total pay in 2014.
Goldenberg also received $286.4K in non-equity incentive plan, $350K in option awards, $584.5K in salary and $153.2K in other compensation.
Rankings
In 2014, David M. Goldenberg's compensation ranked 3,472nd out of 13,032 executives tracked by ExecPay. In other words, Goldenberg earned more than 73.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,472 out of 13,032 | 73rd |
Division Manufacturing | 1,225 out of 4,965 | 75th |
Major group Chemicals And Allied Products | 397 out of 1,690 | 77th |
Industry group Drugs | 308 out of 1,369 | 78th |
Industry In Vitro and In Vivo Diagnostic Substances | 10 out of 72 | 86th |
Source: SEC filing on November 2, 2016.
Goldenberg's colleagues
We found two more compensation records of executives who worked with David M. Goldenberg at Immunomedics in 2014.